Article
HLA-DRB1*16: 01-DQB1*05: 02 is a novel genetic risk factor for flupirtine-induced liver injury.
Pharmacogenetics and genomics - 1 May 2016
Nicoletti Paola, Werk Anneke N, Sawle Ashley, Shen Yufeng, Urban Thomas J, Coulthard Sally A, Bjornsson Einar S, Cascorbi Ingolf, Floratos Aris, Stammschulte Thomas, Gundert-Remy Ursula, Nelson Matthew R, Aithal Guruprasad P, Daly Ann K
Abstract excerpt
OBJECTIVE: Flupirtine is a nonopioid analgesic with regulatory approval in a number of European countries. Because of the risk of serious liver injury, its use is now limited to short-term pain management. We aimed to identify genetic risk factors for flupirtine-related drug-induced liver injury (DILI) as these are unknown. MATERIALS AND METHODS: Six flupirtine-related DILI patients from Germany were included in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
